Cognitive impairment in opioid use disorders: Is there a case for use of nootropics?

Abstract

Opioid Use Disorders (OUDs) are often associated with cognitive impairments, which may lead to an increased risk of relapse. These cognitive deficits do not resolve with abstinence or medication-assisted treatment and may require targeted management. While psychotherapies and neuromodulation techniques have been studied for their effectiveness, they have certain limitations and challenges. Cognition enhancing prescription drugs like donepezil and memantine, which are used in dementias, have shown promise in a small number of studies examining their role in the reversal of opioid-induced cognitive deficits. The authors explore the potential role of nootropics in improvement of cognitive decline associated with OUDs.

• Authors: Gayatri Bhatia, Ragul Ganesh, Alok Kulkarni
• Journal: Psychiatry research (Psychiatry Res) Vol. 326 Pg. 115335 (Aug 2023) ISSN: 1872-7123 [Electronic] Ireland
• PMID: 37459675 (Publication Type: Journal Article)
• Copyright: Copyright © 2023 Elsevier B.V. All rights reserved.